英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
Aprepitant
|
170729-80-3 |
阿瑞吡坦
|
阿瑞吡坦;阿瑞匹坦;阿瑞比坦;阿瑞吡坦杂质;5-[2(R)-[1(R)-[3,5-二(三氟甲基)苯基]乙氧基]-3(S)-(4-氟苯基)吗啉-4-基甲基]-3,4-二氢;阿瑞匹坦 (API);阿瑞匹坦170729-80-3,抗肿瘤药170729-80-4
|
C23H21F7N4O3 |
534.426662 | 677-636-6 |
disodiumcromoglycate
|
15826-37-6 |
色甘酸钠
|
色甘酸钠;5,5'-[2-羟基-1,3-丙烷基双-(氧)]双[4-氧代-4H-1-苯并吡喃-2羧酸]二钠盐;咳乐钠;色甘酸二钠;咽泰;色甘酸钠盐,99%;克罗莫林钠杂质;色甘酸二钠盐
|
C23H14Na2O11 |
248.3 | 239-926-7 |
LRRK2-IN-1
|
1234480-84-2 |
5,11-二氢-2-[[2-甲氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮
|
5,11-二氢-2-[[2-甲氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮;哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,4]苯并二氮杂卓-6-酮;CS-642;LRRK2-IN-1;LRRK2 INHIBITOR
|
C31H38N8O3 |
571 | |
TMPyP4 tosylate
|
36951-72-1 |
TMPYP[=Α,Β,Γ,Δ-四(1-甲基吡啶嗡-4-基)卟吩对甲苯磺酸盐][铜和镁用超高灵敏分光光度试剂][用于以高效液相色谱金属同时测定]
|
5,10,15,20-四(N-甲基-4-吡啶)卟吩对甲苯磺酸盐;TMPYP[=ALPHA,BETA,GAMMA,DELTA-四(1-甲基吡啶翁)卟吩对甲苯磺酸盐;MESO-四(N-甲基-4-吡啶基)卟吩四甲苯磺酸酯;5,20-四(1-甲基-4-吡啶基)卟啉四(对甲苯磺酸盐);TMPYP[=Α,Β,Γ,Δ-四(1-甲基吡啶嗡-4-基)卟吩对甲苯磺酸盐];TMPYP[=Α,Δ-四(1-甲基吡啶嗡-4-基)卟吩对甲苯磺酸盐](>98.0%(N));四(1-甲基吡啶嗡-4-基)卟吩对甲苯磺酸盐;内消旋-四(N-甲基-4-吡啶基)卟吩 四甲苯磺酸盐
|
C44H38N8+4 |
1363.6 | |
TC-E 5002
|
1453071-47-0 |
N-(9-环丙基-1-氧代壬基)-N-羟基-Β-丙氨酸
|
N-(9-Cyclopropyl-1-oxononyl)-N-hydroxy-beta-alanine;N-(9-Cyclopropyl-1-oxononyl)-N-hydroxy-β;N-(9-Cyclopropyl-1-oxononyl)-N-hydroxy-β-alanine;TC-E 5002
|
|||
Nepicastat hydrochloride
|
170151-24-3 |
NEPICASTAT HYDROCHLORIDE
|
NEPICASTAT HYDROCHLORIDE;内匹司他盐酸盐;SYN-117 HYDROCHLORIDE;RS-25560-197 HYDROCHLORIDE;(S)-5-(氨基甲基)-1-(5,7-二氟-1,2,3,4-四氢萘-2-基)-1H-咪唑-2(3H)-硫酮盐酸盐;盐酸内匹司他
|
C14H16ClF2N3S |
331.812 | |
A 887826
|
1266212-81-0 |
5-(4-丁氧基-3-氯苯基)-N-[[2-(4-吗啉)-3-吡啶基]甲基]-3-吡啶甲酰胺
|
A 887826;5-(4-Butoxy-3-chlorophenyl)-N-[[2-(4-Morpholinyl)-3-pyridinyl]Methyl]-3-pyridinecarboxaMide
|
|||
DQP 1105
|
380560-89-4 |
5-(4-BROMOPHENYL)-3-(1,2-DIHYDRO-6-METHYL-2-OXO-4-PHENYL-3-QUINOLINYL)-4,5-DIHYDRO-G-OXO-1H-PYRAZOLE-1-BUTANOIC ACID
|
5-(4-BROMOPHENYL)-3-(1,2-DIHYDRO-6-METHYL-2-OXO-4-PHENYL-3-QUINOLINYL)-4,5-DIHYDRO-G-OXO-1H-PYRAZOLE-1-BUTANOIC ACID
|
C29H24BrN3O4 |
558.42256 | |
Axitinib
|
319460-85-0 |
阿西替尼
|
阿西替尼;AG-013736;AG 013736;AG013736;阿西替尼中;阿西替尼,AXITINIB;阿西替尼;N-甲基-2-((3-((1E)-2-(吡啶-2-基)乙烯)-1H-吲唑-7-基)硫)苯甲酰胺;阿西替尼杂质 (AXITINIB IMPURITY;阿西替尼(包括部分杂质)
|
C22H18N4OS |
386.47 | 638-771-6 |
CCG 203971
|
1443437-74-8 |
1443437-74-8
|
CCG 203971;CCG203971;CCG-203971
|
C23H21ClN2O3 |
408.87744 | |
Rivastigmine tartrate
|
129101-54-8 |
酒石酸卡巴拉汀
|
酒石酸利斯的明(酒石酸利伐斯的明);酒石酸利伐斯的明;卡巴拉汀酒石酸盐;重酒石酸卡巴拉汀;L-酒石酸卡巴拉汀;酒石酸卡巴拉汀,乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂;酒石酸卡巴拉汀;酒石酸利伐斯的明;酒石酸卡巴拉汀129101-54-9
|
C14H22N2O2·C4H6O6 |
400.43 | 603-318-3 |
Artesunate
|
88495-63-0 |
青蒿琥酯
|
还原青蒿琥珀酸单酯;青蒿琥脂;青蒿酯;ARTESUNATE 青蒿琥酯 标准品;青蒿虎脂;青蒿琥酯,99%;青蒿琥酯杂质;青蒿酯、青蒿琥酯
|
C19H29O8;C19H28O8 |
384.42 | 618-170-5 |
BSI-201 (Iniparib)
|
160003-66-7 |
3-硝基-4-碘苯甲酰胺
|
INIPARIB;NSC-746045;IND-71677;BSI 201;BSI201;3-硝基-4-碘苯甲酰胺;CS-420;4-碘-3-硝基苯甲酰胺
|
C7H5IN2O3 |
292.03 | 685-396-9 |
Salmeterol xinafoate
|
94749-08-3 |
昔美酸沙美特罗
|
2-羟甲基-4-[1-羟基-2-[6-(4-苯基丁氧基)己基氨基]乙基]苯酚 1-羟基-2-萘甲酸盐;沙美特罗羟萘甲酸盐;昔美酸沙美特罗;沙美特罗羟萘甲酸盐/2-羟甲基-4-[1-羟基-2-[6-(4-苯基丁氧基)己基氨基]乙基]苯酚 1-羟基-2-萘甲酸盐;甲醇中沙米特罗溶液标准物质;沙美特罗羟萘甲酸盐:昔美酸沙美特罗;苯磺阿曲库铵;葛兰素威
|
C25H37NO4.C11H8O3 |
603.75 | |
1-(4-hydroxy-3-methoxyphenyl)ethanone
|
498-02-2 |
4-羟基-3-甲氧基苯乙酮
|
香草乙酮(4-羟基-3-甲氧基苯乙酮);3-甲氧基-4-羟基苯乙酮;香草乙酮;3-甲氧基-4-羟基苯乙酮;香草酮;香草乙酮;罗布麻宁.乙酰香草酮.茶叶花宁;香草酮;香草乙酮;夹竹桃麻素(标准品);ACETOVANILLONE 香草酮;香草乙酮
|
C9H10O3 |
166.18 | 207-854-5 |
SB 743921
|
940929-33-9 |
SB 743921; (R)-N-(3-AMINOPROPYL)-N-(1-(3-BENZYL-7-CHLORO-4-OXO-4H-CHROMEN-2-YL)-2-METHYLPROPYL)-4-METHYLBENZAMIDE HYDROCHLORIDE
|
N-(3-氨基丙基)-N-[(1R)-1-[7-氯-4-氧代-3-(苯基甲基)-4H-1-苯并吡喃-2-基]-2-甲基丙基]-4-甲基苯甲酰胺盐酸盐
|
C31H34Cl2N2O3 |
553.51926 | |
PHT-427
|
1191951-57-1 |
4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺
|
4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺;PHT-427;PHT 427;CS-303
|
C20H31N3O2S2 |
409.62 | |
1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea
|
792173-99-0 |
1-(2-甲基苯并[D]噁唑-6-基)-3-(1,5-萘啶-4-基)脲
|
N-(2-METHYL-6-BENZOOXAZOLYL)-N''-1,5-NAPHTHYRIDIN-4-YL UREA;1-(2-methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea;SB-334867 (free base);1-(2-Methylbenzo[d]oxazol-5-yl)-3-(1,5-naphthyridin-4-yl)urea;N-(2-Methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-ylurea SB334867;N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl;SB-334867,CID 6604926;SB334867/SB-334867
|
C17H13N5O2 |
319.31742 | |
N-(Hydroxyethyl)piperazine-N'-2-hydroxypropanesulfonic acid
|
68399-78-0 |
3-(羟乙基哌嗪)-2-羟基丙磺酸
|
4-(2-羟乙基)哌嗪-1-2-羟基丙磺酸,超纯级;HEPPSO BUFFER(HEPPSO缓冲液),0.2M,PH8.5;4-(2-羟乙基)哌嗪-1-2-羟基丙磺酸(HEPPSO);HEPPSO BUFFER(HEPPSO缓冲液),PH8.0;HEPPSO BUFFER(HEPPSO缓冲液),PH7.5;HEPPSO BUFFER( HEPPSO缓冲液),PH7.0;HEPPSO缓冲液;N-(2-羟乙基)哌嗪-N'-(2-羟基丙磺酸)
|
C9H20N2O5S |
268.33 | 269-990-1 |
EMPA
|
680590-49-2 |
N-ETHYL-2-[(6-METHOXYPYRIDIN-3-YL)-(2-METHYLPHENYL)SULFONYLAMINO]-N-(PYRIDIN-3-YLMETHYL)ACETAMIDE
|
N-ETHYL-2-[(6-METHOXYPYRIDIN-3-YL)-(2-METHYLPHENYL)SULFONYLAMINO]-N-(PYRIDIN-3-YLMETHYL)ACETAMIDE
|
C23H26N4O4S |
454.54194 |